PubRank

Wesley L Hicks

Author PubWeight™ 31.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Head and neck cancers. J Natl Compr Canc Netw 2011 1.64
2 Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2014 1.39
3 Ameloblastic carcinoma: report of an aggressive case with multiple bony metastases. Am J Otolaryngol 2003 1.35
4 Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013 1.35
5 Oropharyngeal cancer: current understanding and management. Curr Opin Otolaryngol Head Neck Surg 2009 1.31
6 Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck 2013 1.23
7 Adenoid cystic carcinoma of the paranasal sinuses or nasal cavity: a 40-year review of 35 cases. Ear Nose Throat J 2002 1.09
8 Head and neck cancers. J Natl Compr Canc Netw 2008 1.01
9 Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 2003 1.00
10 Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Am J Clin Oncol 2009 0.97
11 Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J 2004 0.93
12 Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res 2004 0.92
13 Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck 2010 0.92
14 Head and neck cancers. J Natl Compr Canc Netw 2005 0.91
15 Quantification of the effect of treatment duration on local-regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Head Neck 2012 0.90
16 Mucosal melanoma of the head and neck. J Natl Compr Canc Netw 2012 0.89
17 Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction. Arch Otolaryngol Head Neck Surg 2003 0.86
18 Tailored delivery of active keratinocyte growth factor from biodegradable polymer formulations. J Biomed Mater Res A 2003 0.85
19 Sentinel lymph node biopsy in SCC of the head and neck: a major advance in staging the N0 neck. Ear Nose Throat J 2002 0.84
20 Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopathologic characteristics and treatment outcomes. Ann Surg Oncol 2003 0.84
21 Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways. Support Care Cancer 2013 0.82
22 Bronchogenic cyst presenting as a symptomatic neck mass in an adult: case report and review of the literature. Laryngoscope 2004 0.82
23 Human papillomavirus and tobacco use in tongue base cancers. Ear Nose Throat J 2013 0.82
24 Possible impedance of luminal reepithelialization by tracheal cartilage metalloproteinases. Arch Otolaryngol Head Neck Surg 2003 0.81
25 Hypotensive endovascular test occlusion of the carotid artery in head and neck cancer. Neurosurg Focus 2003 0.80
26 Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 2002 0.79
27 Current concepts in the management of a second malignancy of the lung in patients with head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2003 0.78
28 Vascular priming enhances chemotherapeutic efficacy against head and neck cancer. Oral Oncol 2013 0.78
29 Survival differences between organ preservation surgery and definitive radiotherapy in early supraglottic squamous cell carcinoma. Otolaryngol Head Neck Surg 2013 0.78
30 Phase separation at the surface of poly(ethylene oxide)-containing biodegradable poly(L-lactic acid) blends. Langmuir 2009 0.77
31 Genomic instability measurement in the diagnosis of thyroid neoplasms. Head Neck 2002 0.77
32 Intraparotid sentinel lymph node biopsy for head and neck melanoma. Laryngoscope 2006 0.77
33 Palatal reconstruction. Curr Opin Otolaryngol Head Neck Surg 2012 0.77
34 Pectoralis major myocutaneous flap for reconstruction of circumferential pharyngeal defects. Ann Plast Surg 2013 0.76
35 Papillary thyroid cancer: high inter-(simple sequence repeat) genomic instability in a typically indolent cancer. Head Neck 2003 0.76
36 Comparative genomic instabilities of thyroid and colon cancers. Arch Otolaryngol Head Neck Surg 2007 0.75
37 Is there disparity in the care of minority patients with upper aerodigestive tract malignancy? Med Clin North Am 2005 0.75
38 Advanced soft palate cancer: the clinical importance of the parapharyngeal space. Otolaryngol Head Neck Surg 2005 0.75
39 Guest aggregation within poly(L-lactic acid)/pluronic P104 thin films. Appl Spectrosc 2008 0.75
40 Determining the protein drug release characteristics and cell adhesion to a PLLA or PLGA biodegradable polymer membrane. J Biomed Mater Res A 2010 0.75